T. Rowe Price (TROW)
NASDAQFinancialsAsset ManagementSnapshot 2026-07-07
$120.16+0.87%
Close 2026-07-07 · 1-day change
Reading TROW? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TROW free→NASDAQFinancialsAsset ManagementSnapshot 2026-07-07
Reading TROW? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track TROW free→QuarterlyIQ Insights · TROW
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 12 valuation methods, at three horizons. Current price $120.16. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $120 TROW trades at 12× p/e, below its 19× p/e peer median, but our blended $114 fair value sits below the price. We hold it with medium confidence: quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $87–$111. Note: our $114 fair value sits above the entire analyst range ($87–$111). Not investment advice.
$87.00 – $111.00 (median $101.00) · 8 analysts · as of 2026-06-26
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $101.00 | — | — | Analyst | high |
| dcf fcfe | 12M | $246.09 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $263.99 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $82.53 | — | — | TTM | high |
| graham number | 12M | $106.39 | — | — | TTM | high |
| Peer P/B | 12M | $83.82 | 1.7 | 50.25 | TTM | high |
| Peer P/FCF | 12M | $138.31 | 13.8 | 9.99 | TTM | high |
| Peer P/E | 12M | $185.69 | 18.6 | 10.01 | TTM | high |
| Peer P/S | 12M | $100.85 | 3.0 | 34.04 | TTM | high |
| residual income | 12M | $71.62 | — | — | TTM | high |
| Own P/E history | 12M | $109.41 | 10.9 | 10.01 | TTM | high |
| triangulated | 12M | $187.93 | 18.6 | 10.13 | Triangulated | high |
| Peer P/B | 3Y | $99.20 | 1.7 | 59.47 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $197.24 | 13.8 | 14.25 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $176.17 | 18.6 | 9.50 | Analyst | medium |
| Peer P/S | 3Y | $113.10 | 3.0 | 38.18 | Analyst | medium |
| Own P/E history | 3Y | $103.80 | 10.9 | 9.50 | Analyst | medium |
| Peer P/B | 5Y | $110.99 | 1.7 | 66.54 | Hist. CAGR(prov.) | high |
| Peer P/FCF | 5Y | $249.89 | 13.8 | 18.05 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $170.09 | 18.6 | 9.17 | Analyst | high |
| Peer P/S | 5Y | $121.89 | 3.0 | 41.15 | Analyst | high |
| Own P/E history | 5Y | $100.22 | 10.9 | 9.17 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.